| 000 | 01823 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515071757.0 | ||
| 264 | 0 | _c20080211 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a0167-594X | ||
| 024 | 7 |
_a10.1007/s11060-007-9410-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsiouris, Spyridon | |
| 245 | 0 | 0 |
_aPentavalent technetium-99m dimercaptosuccinic acid [99m Tc-(V)DMSA] brain scintitomography--a plausible non-invasive depicter of glioblastoma proliferation and therapy response. _h[electronic resource] |
| 260 |
_bJournal of neuro-oncology _cDec 2007 |
||
| 300 |
_a291-5 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 |
_aGlioblastoma _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xdiagnostic imaging |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnostic imaging |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aTechnetium Tc 99m Dimercaptosuccinic Acid |
| 650 | 0 | 4 | _aTomography, Emission-Computed |
| 650 | 0 | 4 | _aTomography, Emission-Computed, Single-Photon |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPirmettis, Ioannis | |
| 700 | 1 | _aChatzipanagiotou, Theodoros | |
| 700 | 1 | _aPtohis, Nikolaos | |
| 700 | 1 | _aPapantoniou, Vassilios | |
| 773 | 0 |
_tJournal of neuro-oncology _gvol. 85 _gno. 3 _gp. 291-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11060-007-9410-7 _zAvailable from publisher's website |
| 999 |
_c17093376 _d17093376 |
||